-
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
16 May 2022 13:56 GMT
… . SYRS (before the market open)
Chimerix, Inc. CMRX (before the market … Sidelines For Wave Life Sciences
IPOs
IPO Pricing
OKYO Pharma Limited OKYO … 65 ordinary shares, in an initial public offering in the U.S. The …
-
Chimerix: Down But Not Out
06 Jun 2022 08:35 GMT
… small, intriguing biotech development called Chimerix (NASDAQ:CMRX). As we … in May. We revisit Chimerix below. Seeking Alpha Company … significantly diminished. That said, Chimerix is an interesting … the Biotech Forum, Busted IPO Forum, and Insiders Forum …
-
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
04 Nov 2021 12:37 GMT
… Kidney Conference, More IPOs In The Pipeline
Chimerix Sinks On Safety Concerns … Its Brain Tumor Treatment Candidate
Chimerix (NASDAQ: CMRX) announced topline … )
IPOs
Hamburg, Germany-based Evotec SE (NASDAQ: EVO) priced its downsized initial public offering …
-
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
31 Oct 2021 19:30 GMT
… FULC) (before the market open)
Chimerix, Inc. (NASDAQ: CMRX) (before … (before the market open)
IPO Calendar
IPO Pricing
Hamburg, Germany-based … for a 22-million ADS initial public offering at a price of … symbol "NVCT."
IPO Quiet Period Expiry
Theseus …
-
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep 2021 11:54 GMT
… Liquidates Equity Interest In Chimerix
Cantex Pharma announced that … IPOs
Procept Biorobotics Corporation (NASDAQ: PRCT) priced its upsized initial public offering … , priced its upsized IPO of 10.8 million … disorders, priced its upsized IPO of 4.8 million …
-
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
01 Aug 2021 14:49 GMT
… also witnessed a slew of IPOs from among biopharma, diagnostics and … : VRNA) (before the market open)
Chimerix, Inc. (NASDAQ: CMRX) (before … )
IPOs
IPO Pricing
Philadelphia, Pennsylvania-based Context Therapeutics, Inc. is planning an initial public offering …
-
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
10 Feb 2021 12:44 GMT
…
ChemoCentryx Inc (NASDAQ: CCXI)
Chimerix Inc (NASDAQ: CMRX)
Clearpoint … (after the market close)
IPOs
French clinical-stage biotech Biophytis … with aging, priced its initial public offering of 1.2 million … system disorders, priced its IPO of $2.25 million …
-
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
08 Jan 2021 12:37 GMT
… in after-hours trading.
Chimerix Buys Oncology Biotech Oncoceutics … .
On The Radar
IPOs
China-based Gracell Biotechnologies … therapy company, priced its initial public offering of 11 million ADSs … patients, priced its upsized initial public offering of 11. 9 …
-
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
16 Dec 2020 12:27 GMT
…
BioTelemetry Inc (NASDAQ: BEAT)
Chimerix Inc (NASDAQ: CMRX)
Corcept … listed on Friday following its IPO)
Aptose Biosciences Inc (NASDAQ … (before the market open)
IPOs
San Diego, California-based … it priced its upsized initial public offering of 10.5 million …